NICE recommendation for Sanofi and Regeneron’s CSCC treatment
Libtayo has been approved for adults when curative surgery or radiation is not appropriate
26th May 2022
Libtayo has been approved for adults when curative surgery or radiation is not appropriate
26th May 2022
Approval provides another step forward in transforming multiple myeloma outcomes and eliminating the disease
26th May 2022
Technology is already being used in clinical trials of new treatments for Alzheimer’s and new studies will provide additional validation
25th May 2022
Companies say that three-dose vaccine for children aged six months to five years old is 80% effective at preventing illness
24th May 2022
Less invasive procedure offers an equally effective alternative for heart condition patients
24th May 2022
It is the first gene therapy to be directly administered into the brain to treat aromatic L-amino acid decarboxylase (AADC) deficiency
23rd May 2022
Positive opinion is based on data from clinical trials which showed improvement in lung function
23rd May 2022
Thousands usually prescribed sleeping pills could be offered app-based treatment
20th May 2022
Scientists demonstrated that AZD1236 halts oedema while reducing spinal cord breakdown at site of injury
20th May 2022
Comparisons with other tests available have shown that blood test has greater sensitivity for the detection of bowel cancer
19th May 2022
Gifford is supporting the launch with a philanthropic donation of £14.7m
19th May 2022
Device delivers currents to the brain to restore activity usually lowered in depression patients
18th May 2022
Orally available EP395 has met all endpoints in safety and is now undergoing phase 2 planning
18th May 2022
Authorisation of the treatment is based on results from the phase 3 trial
17th May 2022
Team at Imperial College London will expand MELODY study to include immunosuppressed young people
17th May 2022